PropertyValue
?:definition
  • Molecular assay reagents intended to identify mutations in the aspartoacylase (aminoacylase 2) (ASPA) gene, located at chromosome 17p13.3, which encodes for an enzyme that breaks down N-acetyl-L-aspartic acid (NAA) into aspartic acid and acetic acid. NAA is critical for maintaining the white matter of the brain and may also play a role in transporting water molecules out of nerve cells. Mutations at this locus have been identified in most patients with a type of leukodystrophy known as Canavan\'s disease (CD). The disease is also known as Canavan-van-Bogaert Bertrand disease.
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C3689907_UMD>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C3689907_UMD>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all